Science Intelligence and InfoPros

Little things about Scientitic Watch and Information Professionnals

Posts Tagged ‘J&J

Bad story: J&J unit closes a Facebook page

leave a comment »

According Pharmalot:

More than a year after launching its Psoriasis 360 page on Facebook, the Janssen UK unit of Johnson & Johnson is closing down due to a growing number of comments that had to be removed because specific drugs were mentioned or, in some cases, offensive language was used.  (…)

The move comes amid an ongoing debate over the extent to which the pharmaceutical industry can – and should – embrace Facebook and, in general, social media. Last year, Facebook no longer allowed drugmakers to disable posted comments

In fact, the Psoriasis 360 Facebook page was the first in the pharmaceutical industry to allow comments to appear before being vetted by a drugmaker (…)

Read further:

Silverman, Ed. J&J unit closes Facebook page due to comments. PharmaLot, 22nd of March 2012; Available from:
http://www.pharmalot.com/2012/03/jj-unit-closes-facebook-page-due-to-comments/

 

 

 

 

Advertisements

Written by hbasset

March 22, 2012 at 7:18 pm

Posted in Pharmaceutical Industry

Tagged with ,

Pharma goes online: 50 apps from top Big Pharmas

leave a comment »

The popularity of smartphones like the iPhone has created an entirely new marketplace for mobile applications.

Pharmaceutical companies are starting to see the value these apps can provide. A properly designed app-be it a medication tracker, a disease calculator, an educational catalogue, or a patient diary-can improve the lives of patients and physicians and thus increase customer collaboration.

At the same time, a well-designed app in the hands of sales reps and marketers can maximize organizational efficiency and create competitive advantage when it comes to selling drugs.

In the past year, pharma investments in smartphone apps, social media platforms, and wireless devices have grown 78 percent

If you go to the Apple App Store today, you’ll find thousands of medical applications; about 50 of these belong to the pharmaceutical industry. Abbott, AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, and Sanofi-aventis all have apps on the market.

Many of these apps target physicians and nurses:

  • Novartis’ GIST Calculator (Risk of recurrence for Gastrointestinal Stromal Tumors)
  • Roche’s Nursing ACE (educational information for nurses)
  • Johnson & Johnson’s Psoriasis App (calculation of PASI)

or to make the lives of patients better:

  • Merck’s iChemoDiary (record of treatments and medications)
  • Bayer’s Kid-K (gaming for kids with hemophilia)
  • Sanofi-aventis’ GoMeals (nutrition for diabetic population)

When done right, these apps can build a positive association between a brand and a lifestyle and can be integrated into every part of patients’ lives.

Pharma Goes Mobile: Making The Most Of The App Opportunity. Medical News Today, Online, on 24th of March 2011.
http://www.medicalnewstoday.com/articles/220143.php

Written by hbasset

March 30, 2011 at 7:09 pm